Latest Drugs, Latest Approval in Anticoagulant reversal agents

What are Anticoagulant reversal agents?

Anticoagulant reversal agents are required when anticoagulant therapy needs to be reversed or neutralized in situations when there are bleeding complications, an overdose of anticoagulant therapy or unplanned surgery is required.

Name Updated
Phytonadione (oral/injection) (Phytonadione (oral/injection) [ fye-toe-na-dye-own ]) 15-Aug-2023
Coagulation factor xa (Coagulation factor xa [ koe-ag-ue-lay-tion-fak-tor-xa ]) 14-Aug-2023
Prothrombin complex (Prothrombin complex [ pro-throm-bin-kom-plex ]) 12-Aug-2023
Idarucizumab (Idarucizumab [ eye-da-roo-kiz-ue-mab ]) 11-Aug-2023
Andexxa (Coagulation factor xa [ koe-ag-ue-lay-tion-fak-tor-xa ]) 05-Aug-2023
Balfaxar (Prothrombin complex concentrate, human-lans) 28-Jul-2023
Praxbind (Idarucizumab [ eye-da-roo-kiz-ue-mab ]) 13-Jul-2023
Kcentra (Prothrombin complex [ pro-throm-bin-kom-plex ]) 11-Jul-2023